Berman, R. M. , Cappiello, A. , Anand, A. , Oren, D. A. , Heninger, G. R. , Charney, D. S. , & Krystal, J. H. (2000). Antidepressant effects of ketamine in depressed patients. Biological Psychiatry, 47(4), 351–354.
Garcia-Romeu, A. , Griffiths, R. R. , & Johnson, M. W. (2014). Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. Current Drug Abuse Reviews, 7(3), 157–164. doi:10.2174/1874473708666150107121331
Khorramzadeh, E. , & Lotfy, A. O. (1973). The use of ketamine in psychiatry. Psychosomatics, 14(6), 14–346. doi:10.1016/S0033-3182(73)71306-2
Krystal, J. H. , Karper, L. P. , Seibyl, J. P. , Freeman, G. K. , Delaney, R. , Bremner, J. D. , Heninger, G. R. , Bowers, M. B. , & Charney, D. S. (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of general psychiatry, 51(3), 199–214.
Roquet, S. , Favreau, P. , Ocana, R. , & Velasco, M. (1975). The existential through psychodisleptics – A new psychotherapy. Paper presented at “Humanistic Psychology in the Americas” at the Sixth International Conference of the Association for Humanistic Psycho, Instituto de Psicosintesis of the Albert Schweitzer Association, Cuernavaca, Mexico.
Zarate, C. A. , Singh, J. B. , Carlson, P. J. , Brutsche, N. E. , Ameli, R. , Luckenbaugh, D. A. , Charney, D. S. , & Manji, H. K. (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry, 63(8), 856–864. doi:10.1001/archpsyc.63.8.856